Suppr超能文献

皮下抗生素治疗:为何、如何、何种药物及何时。

Subcutaneous Antibiotic Therapy: The Why, How, Which Drugs and When.

机构信息

Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico; CHU de Bordeaux, Pôle de Gérontologie Clinique, Bordeaux, France.

Service de Maladies Infectieuses, CH Métropole Savoie, Chambéry, France.

出版信息

J Am Med Dir Assoc. 2021 Jan;22(1):50-55.e6. doi: 10.1016/j.jamda.2020.04.035. Epub 2020 Jul 14.

Abstract

OBJECTIVES

To describe the rationale for subcutaneous (SC) administration of antibiotics from available published data and to make propositions to help clinicians in daily practice.

DESIGN

Narrative review.

SETTING AND PARTICIPANTS

Hospitalized patients, persons in long-term care facilities and ambulatory care.

METHODS

We searched the MEDLINE/PubMed electronic database for evidence supporting SC administration of antibiotics up to September 2019; the results of this primary search were supplemented by searching the references of the identified articles, as well as by searching in Google Scholar.

RESULTS

Regarding tolerability, efficacy, and pharmacokinetic/pharmacodynamic profiles, most studies suggest that the SC route could be an alternative to the intravenous route, particularly for time-dependent antibiotics and among certain patient populations, such as patients with poor venous access, swallowing disorders, or behavioral disturbance. However, clinical evidence of the benefits and risks of SC antibiotic administration is still scarce and of low level.

CONCLUSIONS AND IMPLICATIONS

SC administration of antibiotics may be useful in various settings such as in hospitalized patients and among those in long-term care facilities or being cared for at home. However, further clinical studies are needed to assess the pharmacokinetic/pharmacodynamic properties, as well as the risks and benefits of SC administration of antibiotics. In this review, we highlight the potential benefits of SC administration of antibiotics and address practical recommendations for its use. This information will enable improvement of treatment strategies and present the SC route as a potential option in specific situations.

摘要

目的

根据现有已发表数据,描述抗生素皮下给药的原理,并提出建议以帮助临床医生在日常实践中应用。

设计

叙述性综述。

设置和参与者

住院患者、长期护理机构中的人员和门诊患者。

方法

我们在 MEDLINE/PubMed 电子数据库中搜索了截至 2019 年 9 月支持抗生素皮下给药的证据;通过对已确定文章的参考文献进行搜索,以及在 Google Scholar 中进行搜索,对该初步搜索的结果进行了补充。

结果

关于耐受性、疗效和药代动力学/药效学特征,大多数研究表明,与静脉途径相比,皮下途径可能是一种替代途径,特别是对于时间依赖性抗生素和某些特定患者群体,如静脉通路不良、吞咽障碍或行为障碍的患者。然而,抗生素皮下给药的临床获益和风险的证据仍然很少且水平较低。

结论和意义

抗生素皮下给药可能在各种情况下有用,例如在住院患者以及在长期护理机构中的患者或在家中接受护理的患者中。然而,需要进一步的临床研究来评估抗生素皮下给药的药代动力学/药效学特性,以及其风险和获益。在本次综述中,我们强调了抗生素皮下给药的潜在获益,并提出了其使用的实用建议。这些信息将有助于改善治疗策略,并将皮下途径作为特定情况下的潜在选择。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验